Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic potential of endotoxin scattering photometry for sepsis and septic shock.

Shock (Augusta, Ga.)·2013
Same author

Comparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria.

Radiology·2013
Same author

Performing simple and safe dunking pancreaticojejunostomy using mattress sutures in pure laparoscopic pancreaticoduodenectomy.

Surgical endoscopy·2013
Same author

Validated Liquid Culture Monitoring System for Lifespan Extension of Caenorhabditis elegans through Genetic and Dietary Manipulations.

Aging and disease·2013
Same author

Acrolein, an α,β-unsaturated carbonyl, inhibits both growth and PSII activity in the cyanobacterium Synechocystis sp. PCC 6803.

Bioscience, biotechnology, and biochemistry·2013
Same author

Myocardial protection in cardiac surgery: a historical review from the beginning to the current topics.

General thoracic and cardiovascular surgery·2013

Related Experiment Video

Updated: May 8, 2026

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
08:47

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

RAGE-Mediated Inflammation, Type 2 Diabetes, and Diabetic Vascular Complication.

Yasuhiko Yamamoto1, Hiroshi Yamamoto

  • 1Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Sciences , Kanazawa , Japan.

Frontiers in Endocrinology
|August 24, 2013
PubMed
Summary

Obesity triggers inflammation and type 2 diabetes via the receptor for advanced glycation end-products (RAGE). RAGE activation in immune cells and adipocytes promotes insulin resistance and diabetic complications.

Keywords:
inflammationobesitypattern-recognition receptorsragetoll-like receptors

More Related Videos

Characterization of a Novel Human Organotypic Retinal Culture Technique
05:51

Characterization of a Novel Human Organotypic Retinal Culture Technique

Published on: June 9, 2021

Related Experiment Videos

Last Updated: May 8, 2026

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
08:47

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

Characterization of a Novel Human Organotypic Retinal Culture Technique
05:51

Characterization of a Novel Human Organotypic Retinal Culture Technique

Published on: June 9, 2021

Area of Science:

  • Immunology
  • Metabolic Disease Research
  • Cellular Biology

Background:

  • Obesity is linked to chronic inflammation and type 2 diabetes.
  • The innate immune system, involving cells like macrophages and pattern-recognition receptors (PRRs), drives inflammatory responses.
  • The receptor for advanced glycation end-products (RAGE) is a key PRR involved in mediating inflammatory danger signals.

Purpose of the Study:

  • To investigate the role of RAGE in obesity-associated inflammation and insulin resistance.
  • To explore the implications of RAGE expression in adipocytes and immune cells.
  • To understand RAGE's contribution to type 2 diabetes and its vascular complications.

Main Methods:

  • Analysis of RAGE expression in relevant cell types (adipocytes, immune cells, endothelial cells, pancreatic β cells).
  • Investigating the association between RAGE signaling and adipocyte hypertrophy.
  • Examining the link between RAGE activity, inflammation, and insulin resistance.

Main Results:

  • RAGE expression is found in adipocytes, immune cells, endothelial cells, and pancreatic β cells.
  • RAGE is implicated in promoting adipocyte hypertrophy and insulin resistance.
  • RAGE-mediated inflammation and adiposity are linked to type 2 diabetes.

Conclusions:

  • RAGE acts as a proinflammatory mediator in obesity.
  • RAGE signaling contributes to insulin resistance and the development of type 2 diabetes.
  • Targeting RAGE may offer therapeutic potential for obesity-related metabolic disorders and diabetic vascular complications.